Ask me anything about... patient and public involvement in research

In this special episode of our podcast, we bring you a series of four short talks about patient and public involvement in research from our annual ‘Experimental Cancer Medicine Demystified’ event that was held earlier this year. In the first talk, Jean Mullin gives an overview of the Patient and Public Involvement (PPI) Group at the Cancer Research UK Cambridge Centre and the Cambridge Experimental Cancer Medicine Centre. Liz Chipchase then shares her personal reflections on being involved in PPI work in Cambridge. You’ll next hear from Dr Cathal McCague about his research into using artificial intelligence in ovarian cancer care. Neil Stutchbury then reveals how patients and the public helped to shape Cathal’s research project. To wrap up, Katie Mills leads a Q&A session where the speakers answer questions that were submitted by members of the public. If you have a question that you would like us to answer in a future podcast episode, or if you have ideas for topics that you would like us to discuss in a future series, please let us know by visiting our website: www.crukcambridgecentre.org.uk/podcast. Jean Mullin is the Lead CRUK Research Nurse at Cambridge University Hospitals NHS Foundation Trust, Patient and Public Involvement Co-Lead at the Cambridge Experimental Cancer Medicine Centre, Co-Director of the CRUK Cambridge Centre’s Nursing and Allied Healthcare Professionals Programme, and Deputy Operations Manager for Clinical Operations at the Cambridge Cancer Trials Centre. Liz Chipchase’s oesophageal cancer was diagnosed at an early stage through her involvement in the Cytosponge clinical trial. As a result, her cancer was treated at Addenbrooke’s Clinical Research Centre using relatively simple endoscopic techniques. She joined the PPI Group at the Cambridge Experimental Cancer Medical Centre and has a strong interest in the development of new techniques for early diagnosis of cancer. Dr Cathal McCague is a Welcome Trust Research Associate and PhD student at the University of Cambridge, and an Honorary Radiology Registrar at Cambridge University Hospitals NHS Foundation Trust. Neil Stutchbury has been a patient representative on the Cambridge Experimental Cancer Medicine Centre PPI Group for four years. He was successfully treated for bladder cancer at Addenbrooke’s Hospital and now enjoys the role of patient advocate. He is also Lead Governor at Cambridge University Hospitals (CUH), a member of the CUH PPI panel, and a member of the CUH Cancer Patient Partnership Group. Katie Mills was a Programme Manager at the Cambridge Experimental Cancer Medicine Centre.